Tag Archives: CYTX

BioTime (NYSE:BTX) Net Loss Widens in Fiscal First Quarter – BTX, HSP, JNJ, CYTX

Posted on May 13, 2013 by Thomas Vedder

The Alameda, California based BioTime, Inc (NYSEMKT:BTX) announced on Friday that net loss for fiscal Q1 was $7.7 million or $0.15 a share, evaluated against a net loss of $5.0 million or $0.10 a share for same period a year …

Posted in Healthcare, Latest Headlines | Tagged BioTime, BTX, Cytori Therapeutics, CYTX, Hospira, HSP, JNJ, Johnson, NASDAQ:CYTX, NYSE:BTX, NYSE:HSP, NYSE:JNJ | Comments Off

Healthcare Sector Overview; Centene (CNC) Stock Plunges after Expected Earnings Drop while Cytori Therapeutics (CYTX) Plans Public Offerings – CNC, CYTX, JNJ, RIGL, WCRX

Posted on December 15, 2012 by Thomas Vedder

Healthcare sector responded negatively on Friday’s trading session and sector plunged -0.18%. If we look at the key movers of the sector so Rigel Pharmaceuticals, Inc (NASDAQ:RIGL) and Warner Chilcott Plc (NASDAQ:WCRX) were major percentage gainer while most active stock …

Posted in Healthcare, Latest Headlines | Tagged Centene, CNC, Cytori Therapeutics, CYTX, JNJ, Johnson, NASDAQ:CYTX, NASDAQ:RIGL, NASDAQ:WCRX, NYSE:CNC, NYSE:JNJ, Rigel Pharmaceuticals, RIGL, Warner Chilcott, WCRX | Comments Off

Healthcare Sector Shows Bearish Weekly Performance; Questcor (QCOR) Unveils New Dividend Plan & Lifts Buyback while Cytori (CYTX) Hikes After Govt. Contract – QCOR, CYTX, JNJ, BMTI, CRY

Posted on October 1, 2012 by Thomas Vedder

Last trading session’s data showed that healthcare sector reacted negatively with -0.51% change. BioMimetic Therapeutics, Inc. (NASDAQ:BMTI) and Cryolife Inc. (NYSE:CRY) were major percentage decliners in this sector while most active stock was Johnson & Johnson (NYSE:JNJ).

Questcor Pharmaceuticals, Inc. …

Posted in Healthcare, Latest Headlines | Tagged BioMimetic Therapeutics, BMTI, CRY, Cryolife, Cytori, CYTX, JNJ, Johnson, NASDAQ:BMTI, NASDAQ:CYTX, NASDAQ:QCOR, NYSE:CRY, NYSE:JNJ, QCOR, Questcor | Comments Off

Healthcare Stocks Get Investors Affection; Onyx Pharmaceuticals (ONXX) and Bayer’s Get FDA approval for Colorectal Cancer Drug While AspenBio (APPY)’s Four Board Members Quit – ONXX, APPY, PFE, APPY, ERB, CYTX

Posted on September 28, 2012 by Geoff Noir

Last trading session’s data showed that Healthcare sector reacted positively with +0.70% change. AspenBio Pharma, Inc. (NASDAQ:APPY) and ERBA Diagnostics Inc. (NYSEAMEX:ERB) were major gainers in this sector while major decliner was Cytori Therapeutics Inc. (USA) (NASDAQ:CYTX).

The South San …

Posted in Healthcare, Latest Headlines | Tagged APPY, AspenBio, Cytori Therapeutics, CYTX, ERB, ERBA Diagnostics, NASDAQ:APPY, NASDAQ:CYTX, NASDAQ:ONXX, NYSE:PFE, NYSEAMEX:ERB, ONXX, Onyx, PFE, Pfizer | Comments Off

Healthcare Stocks Disappoint Investors; Eli Lilly (NYSE:LLY) Cancer Drug Alimta Fails to Extend Study and FDA Rejects Navidea (NYSEAMEX:NAVB) Medicine – LLY, NAVB, PFE, RGEN, CYTX, SNSS

Posted on September 11, 2012 by Thomas Vedder

Investors reacted negatively to the Healthcare sector on first day of the week. Major movement was seen in Repligen Corporation (NASDAQ:RGEN) and Cytori Therapeutics Inc (USA) (NASDAQ:CYTX) on gainers side while Sunesis Pharmaceuticals, Inc (NASDAQ:SNSS) was prominent stock on the …

Posted in Healthcare, Latest Headlines | Tagged Cytori Therapeutics, CYTX, Eli Lilly, LLY, NASDAQ:CYTX, NASDAQ:RGEN, Nasdaq:SNSS, NAVB, Navidea, NYSE:LLY, NYSE:NAVB, NYSE:PFE, PFE, Pfizer, Repligen, RGEN, SNSS, Sunesis | Comments Off

Cytori Therapeutics Shares Surges on FDA Clearance For Fat Graft Device- NASDAQ:CYTX

Posted on March 17, 2012 by Geoff Noir

Shares of Cytori Therapeutics Inc. (NASDAQ:CYTX) surged in excess of 10% on Friday following the medical device maker reported that it get US agreement for a new version of its Puregraft system, which is utilized in cosmetic surgery.

Plastic surgeons …

Posted in Healthcare, Main Post | Tagged Cytori Therapeutics, CYTX, NASDAQ:CYTX | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.